Modern patients are taking control of their own healthcare, from
sharing information with one another to approaching industry
organisations with their concerns. Tarquin Scadding-Hunt at
mdgroup discusses how, in order to appeal to this new wave of
patient-consumers, clinical trial organisers are having to reconsider
key components of trial design, to ensure adequate enrolment.